FDA Oncology Announcements

Multikinase inhibitor × Gastrointestinal × Clear all

2 Announcements

FDA approves lenvatinib for unresectable hepatocellular carcinoma

Drug: Lenvima (lenvatinib) · Multikinase inhibitor
Condition: Gastrointestinal

Regorafenib

Drug: Stivarga tablets (regorafenib) · Multikinase inhibitor
Condition: Gastrointestinal